Brinker Capital Investments’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,296
Closed -$226K 1657
2023
Q1
$226K Sell
1,296
-618
-32% -$111K ﹤0.01% 1457
2022
Q4
$318K Sell
1,914
-601
-24% -$94.2K 0.01% 1123
2022
Q3
$354K Sell
2,515
-551
-18% -$101K 0.01% 1060
2022
Q2
$625K Buy
3,066
+244
+9% +$53.4K 0.01% 898
2022
Q1
$719K Buy
2,822
+234
+9% +$63.5K 0.01% 914
2021
Q4
$849K Buy
2,588
+452
+21% +$142K 0.01% 879
2021
Q3
$579K Hold
2,136
0.01% 939
2021
Q2
$579K Sell
2,136
-11
-0.5% -$2.79K 0.01% 991
2021
Q1
$523K Sell
2,147
-2,130
-50% -$586K 0.01% 891
2020
Q4
$1.23M Buy
4,277
+1,821
+74% +$501K 0.02% 649
2020
Q3
$626K Buy
+2,456
New +$584K 0.01% 839

Other funds holding MLAB

Brinker Capital Investments's MLAB Position: Q2 2023 in Review

Brinker Capital Investments sold out of Mesa Laboratories (MLAB) in Q2 2023, closing a stake of 1,296 shares — an estimated $226K sold.

Brinker Capital Investments first reported a position in MLAB in Q3 2020 and held it in 11 quarters. The position peaked at $1.23M in Q4 2020. 161 funds tracked by Wall St. Rank hold MLAB as of Q2 2023.

  • Brinker Capital Investments reported no remaining Mesa Laboratories position as of Q2 2023 after selling out during the quarter.
  • Brinker Capital Investments sold 1,296 Mesa Laboratories shares in Q2 2023, an estimated $226K.
  • Brinker Capital Investments first reported a position in Mesa Laboratories in Q3 2020 and held it in 11 quarters.
  • Brinker Capital Investments's Mesa Laboratories position peaked at $1.23M in Q4 2020.
  • 161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2023.

Based on Brinker Capital Investments's 13F filing for Q2 2023, filed 31 Jul 2025.